| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,819 |
9,124 |
$2.47M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,089 |
9,981 |
$2.18M |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
1,263 |
1,067 |
$543K |
| A0425 |
Ground mileage, per statute mile |
1,782 |
1,491 |
$443K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,217 |
1,927 |
$367K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
316 |
263 |
$159K |
| 36415 |
Collection of venous blood by venipuncture |
7,889 |
6,876 |
$122K |
| X5622 |
|
616 |
507 |
$112K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,120 |
1,866 |
$103K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
787 |
703 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,381 |
2,138 |
$72K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,963 |
3,206 |
$64K |
| 80306 |
|
3,313 |
3,119 |
$47K |
| 80053 |
Comprehensive metabolic panel |
1,236 |
917 |
$47K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
705 |
584 |
$45K |
| 97803 |
|
652 |
606 |
$28K |
| 73630 |
|
115 |
105 |
$21K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,174 |
550 |
$14K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,211 |
1,083 |
$14K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
348 |
329 |
$11K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
87 |
50 |
$10K |
| 72100 |
|
43 |
39 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
1,891 |
803 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
158 |
150 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
134 |
92 |
$4K |
| 99233 |
Prolong inpt eval add15 m |
64 |
12 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
16 |
14 |
$4K |
| J3490 |
Unclassified drugs |
923 |
364 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
52 |
48 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
118 |
117 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
160 |
151 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
82 |
70 |
$3K |
| 73110 |
|
17 |
12 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
114 |
98 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
94 |
88 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
37 |
30 |
$2K |
| 87210 |
|
123 |
112 |
$2K |
| 87400 |
|
127 |
82 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
86 |
83 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
172 |
150 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
30 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
54 |
36 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
736 |
675 |
$1K |
| 80061 |
Lipid panel |
41 |
38 |
$1K |
| 86900 |
|
16 |
14 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
43 |
$1K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
30 |
26 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
520 |
425 |
$1K |
| 36591 |
|
29 |
14 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55 |
55 |
$1K |
| 82728 |
|
13 |
12 |
$947.41 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
716 |
667 |
$890.85 |
| 86850 |
|
16 |
14 |
$824.41 |
| 83615 |
|
53 |
14 |
$795.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
37 |
37 |
$684.24 |
| J7050 |
Infusion, normal saline solution, 250 cc |
190 |
79 |
$659.48 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
69 |
64 |
$652.78 |
| 81001 |
|
44 |
38 |
$601.85 |
| 86901 |
|
16 |
14 |
$582.70 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
41 |
39 |
$565.04 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
12 |
$527.76 |
| 84443 |
Thyroid stimulating hormone (TSH) |
16 |
12 |
$496.05 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
23 |
22 |
$494.63 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
34 |
27 |
$478.48 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$417.13 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
132 |
127 |
$375.59 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
113 |
63 |
$365.24 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
59 |
49 |
$189.20 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
71 |
66 |
$162.57 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$115.85 |
| 0004A |
|
13 |
13 |
$82.08 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
21 |
13 |
$46.65 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
13 |
12 |
$27.07 |
| 92551 |
|
53 |
47 |
$23.80 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
13 |
$20.16 |
| 99173 |
|
52 |
44 |
$3.19 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
416 |
391 |
$0.00 |
| 83605 |
|
15 |
13 |
$0.00 |
| 91300 |
|
36 |
33 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13 |
12 |
$0.00 |